Claire Imbratta

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “OMIP‐101: 27‐color flow cytometry panel for immunophenotyping of major leukocyte populations in fixed whole blood”.

OMIP‐101: 27‐color flow cytometry panel for immunophenotyping of major leukocyte populations in fixed whole blood

Cytometry Part A(2024)10.1002/cyto.a.24827

N/A

0DataRank · unranked

13 citations

Timothy D. Reid, Asma Toefy, Thomas J. Scriba, Elisa Nemes, Claire Imbratta

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

The Lancet Global Health(2025)10.1016/s2214-109x(25)00046-4

N/A

0DataRank · unranked

17 citations

Virginie Rozot, Claire Imbratta, Frances Ratangee, Justin Shenje, Michèle Tameris +62 more

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

EBioMedicine(2025)10.1016/j.ebiom.2025.105628

N/A

0DataRank · unranked

12 citations

Virginie Rozot, Claire Imbratta, Hennie Geldenhuys, Simon C. Mendelsohn, Angelique Kany Kany Luabeya +58 more